What it is
Tesamorelin is a stabilized synthetic analog of growth hormone releasing hormone and is FDA-approved for a specific indication: reduction of excess visceral abdominal fat in HIV-associated lipodystrophy.
How it's described to work
It stimulates the pituitary to release growth hormone in a physiologic pattern, and its clinical research is centered on visceral adipose tissue specifically.
What research discusses it for
Visceral fat researchMetabolic researchCognitive aging research
Important context
Off-label discussion here is educational. Eligibility, if any, would be determined by a provider after screening.